Navigation Links
HepaLife Announces Scientific Presentation of PBS-1 Cell Line at,International Influenza Meeting

eed for exogenous proteases, thus simplifying downstream processing. Additionally, PBS-1 cells are free of any exogenous agents, are non-tumorigenic, and are readily adaptable to a variety of culture conditions, including growth on microcarrier beads.

(For more information on recent research findings, please click on the following links: http://www.hepalife.com/20070328-1.html.php or http://www.hepalife.com/20070122-1.html.php)

Protected by five issued patents, HepaLife is developing production methods to make flu vaccines faster, safer and at less cost by means of the Company's patented PBS-1 line of cells.

HepaLife's non-mammalian PBS-1 cell line is derived from an immortalized chicken embryo cell, and is being developed for more flexible cell-culture based vaccine production with the ability to quickly address prospective mutations in the avian influenza virus.

(View a CBS-affiliate, WWMT, television news story about HepaLife's active cell based vaccine research: www.hepalife.com/media)

ABOUT HEPALIFE TECHNOLOGIES, INC.

HepaLife Technologies, Inc. (OTCBB: HPLF - News; FWB: HL1) (WKN: 500625) is a development stage biotechnology company focused on the identification, development and eventual commercialization of cell based technologies and products.

Current cell based technologies under development by HepaLife include 1) the first-of-its-kind artificial liver device, 2) proprietary in-vitro toxicology and pre-clinical drug testing platforms, and 3) cell-culture based vaccines to protect against the spread of influenza viruses among humans, including potentially the high pathogenicity H5N1 virus.

For additional information, please visit www.hepalife.com.

To receive future press releases via email, please visit: http://www.hepalife.com/Alerts-Index.asp

To view the full HTML text of this release, please visit: http://www.hepalife.com/20070529-1.html.php

Legal Notice Regarding Forward-Looking
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
(Date:11/6/2009)...wswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc...Tuesday, November 10, 2009 at 8:30 a.m. EST to dis...business outlook for the remainder of 2009. Ron B...ll host the call. Keryx will announce its financi...e issued prior to the call. ,, In order to part...
(Date:11/6/2009)...swire-FirstCall/ -- Caraco Pharmaceutical Laborato...ac tromethamine ophthalmic solution, 0.5% followin...istration (FDA) for Sun Pharma,s Abbreviated New D...thalmic solution on the first day following patent...utically equivalent to Acular® Ophthalmic Sol...
(Date:11/5/2009)..., Nov. 5 Transcept Pharm...rmaceutical company focused on the development and...dress important therapeutic needs in the field of ...st and teleconference with management to discuss t...ovember 12, 2009, at 5:00 p.m. Eastern Standard Ti...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Apieron Inc Files Infringement Complaint Against Aerocrine AB Aerocrine AG and Mr Magnus Pelles 51909 1St Alexius Medical Center Named to Americas Best Hospitals Rankings 51905 1St Alexius Medical Center Named to Americas Best Hospitals Rankings 51905 2TOPICA Elects G Kirk Raab as Chairman of the Board 51901 1TOPICA Elects G Kirk Raab as Chairman of the Board 51901 2
... annual program,that helps control rabies in wild ...ulture Secretary Dennis Wolff said today., The or...r parts of,Allegheny, Armstrong, Beaver, Butler, C...Mercer, Venango, Washington and Westmoreland count...nimals is essential to human,and domestic animal h...
...at the European Society of Cardiology Continue ...ogy, CARLSBAD, Calif., Sept. 2 Ablation Frontier..., involving its innovative atrial,fibrillation abl... of the,St. Antonius Hospital in Nieuwegein, Nethe... congress. One of the world,s most prestigious sci...
Other Medicine Technology:Rabies Vaccination Program Underway in Western Pennsylvania 2Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies 2Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies 3
(Date:11/7/2009)...lics have a responsibility to vigorously oppose ab...." ,, WASHINGTON, Nov. 7 /PRNewswire-USNews...wn released the following statement on the news th...cy Pelosi,s Affordable Health Care for America Act... status quo for abortion is voted upon. ,, "Ou...
(Date:11/7/2009)...wswire-USNewswire/ -- Speaker Nancy Pelosi and Dem...ernoon following a Democratic Whip meeting with Pr...e the Speaker,s opening remarks: ,, "Thank you...n for us to receive the President of the United St...th our vote and making progress for the American p...
(Date:11/7/2009)...Relations Society of America (PRSA) will bestow th...ren, senior vice president of Brand Strategy, Comm...t a ceremony at PRSA,s 2009 International Conferen...A College of Fellows is one of the profession,s hi..., SAGE, Fellow PRSA, and 2009 chair of the College...
(Date:11/7/2009)...owing problem across the U.S. , , SATURDAY...ts at four-year colleges do it regularly (and, it,...ng five or more alcoholic drinks at a sitting. , "...rug," said Jenny Hwang, associate dean of students...ook University on Long Island, N.Y. In fact, she s...
(Date:11/7/2009)...e current economic climate, many Americans are mon...nding money on what that they consider to be absol...d D. Kim believes that it’s very important f...reatment to improve their health, and he is trying...s in this tough economy by offering reasonable pri...
Breaking Medicine News(10 mins):Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3
... has claimed that 'Harry Potter is dead'. ...d 'HarryPotter-TheDeathlyHallows.doc', the title ... The virus - known as Hairy-A - works by infe...h time the device is inserted. Its other e...
...eakthrough in the research on male infertility, sc...esearch in New York say they have found that the l...nhibitory factor (MIF) in semen could be the key. ...raception, Yousef Al-Abed and his colleagues say....
...he J. Craig Venter Institute (JCVI) today announce...thods allowing them to transform one type of bacte... chromosome. The work, published online in t...sma capricolum into another, Mycoplasma mycoides L...
...cale rape and mass displacement of people in sub-S...rate of HIV/AIDS, the United Nations refugee agenc... belief" of such a link, a new study by the UN Hig...ng host communities. The study, led by Pau...
...tical group Sanofi-Aventis said Friday it had with...ts anti-obesity drug Acomplia in the United States... Drug Administration concluded earlier this month ...will work towards submitting the rimonabant file t...
... it for fourteen years and when he finally started...nths to rebuild Noah's Ark. Huibers, a jo...e idea to build his ark after having a dream that ...P on his finished ark. He stressed, he doe...
Other Medicine News:Health News:Immune System Protein Could Be the Key Infertility 2Health News:First Bacterial Genome Transplantation Changing One Species to Another 2Health News:No Clear Link Between Conflict, Rape and HIV: UN Study 2Health News:Dutchman Rebuilds Noah's Ark to Spread His Faith 2Health News:Dutchman Rebuilds Noah's Ark to Spread His Faith 3
GluStitch® Monograph
Affinity™ DC Pacemakers
Affinity DR 5330R
...odel 1688 and model 1488 active-fixation leads are... pacing leads, offering the unsurpassed handling a... St. Jude Medical's line of active-fixation leads....dy diameter of the Tendril SDX lead is designed to...
Medicine Products: